“Avicenna – A Strategy for in silico Clinical Trials” was a Coordination and Support Action funded by the European Commission. Avicenna was tasked with writing a Roadmap to define the strategy for developing In Silico Clinical Trials.
The main goal of the CombiMS project is to identify a new method for drug discovery based on systems biology and to validate this approach by identifying novel combination therapies for Multiple Sclerosis.
The main goal of the PRIAT Project consists in the development and use of HLA peptidome analysis for the study of interpatient and intrapatient variations in the immunopeptidome in response to antibody treatment.
The PerMed consortium has 27 international partners representing key decision makers in research and research policy, industry, healthcare and patient organisations. The aim is to develop a Strategic Research and Innovation Agenda (SRIA) to foster research and implementaion of suitable Personalized Medicine (PM) approaches in Europe and beyond.
The Vistera Project aims at fostering the transition from the reactive practice of medicine to a more proactive management of health and wellness based on the principles of Systems P4 Medicine (Participatory, Personalized, Predictive and Preventive).
The Coordinating Action Systems Medicine (CASyM) will assess the basis for a European Systems Medicine paradigm and will assist the medical community in creating the foundation for a new perspective by focusing on an approach based on personalized, predictive, preventive and participatory (4P medicine).
Under Horizon 2020, the EU has funded the 3.5 million project MedBioinformatics. This project aims to develop bioinformatics tools and applications for analysing the huge amount of data and knowledge generated in healthcare and biomedical research in order to facilitate translational research and precision medicine.